Investigating how alcohol affects breast cancer and treatment outcomes
Alcohol and Breast Cancer: Genetic Interactions and Effects on Aromatase Inhibitor Therapy
This study is looking at how drinking alcohol might affect breast cancer treatment, especially for those taking aromatase inhibitors, and it aims to find out if your genes play a role in this connection, so that doctors can offer more personalized care for patients like you.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard School of Public Health NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10680436 on NIH RePORTER |
What this research studies
This research explores the relationship between alcohol consumption and breast cancer, focusing on genetic factors that may influence this connection. It aims to understand how alcohol intake can affect the effectiveness of aromatase inhibitor therapy in breast cancer patients. The study involves analyzing genetic data and assessing cancer outcomes through a combination of epidemiological methods and clinical trials. Patients may benefit from insights that could lead to personalized treatment strategies based on their genetic makeup and alcohol use.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with breast cancer who have a history of alcohol consumption.
Not a fit: Patients who do not consume alcohol or those without a breast cancer diagnosis may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for breast cancer patients who consume alcohol.
How similar studies have performed: Previous research has shown promising results in understanding the interactions between lifestyle factors like alcohol and cancer outcomes, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Harvard School of Public Health — Boston, United States (Active)
Researchers
- Principal investigator: Mostofsky, Elizabeth — Harvard School of Public Health
- Study coordinator: Mostofsky, Elizabeth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.